Evidence map›Paper›PMID 39792537›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2025

Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease: A Systematic Review and Meta-Analysis.

Bernardo F Spiazzi, Giovana F Piccoli, Laura F Wayerbacher, João Pedro N Lubianca, Bruno G Scalco, Mariana H Scheffler, Bruna L Fraga, Verônica Colpani, Fernando Gerchman

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bernardo F SpiazziPost-graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0001-6392-3054
Giovana F PiccoliPost-graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0003-3281-4554
Laura F WayerbacherFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0001-9884-0654
João Pedro N LubiancaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-2973-6850
Bruno G ScalcoFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0009-0002-9465-711
Mariana H SchefflerPost-graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-8077-6604
Bruna L FragaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0009-0005-7722-9174
Verônica ColpaniPost-graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-7908-4213
Fernando GerchmanPost-graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0001-5873-9498

Funding

Hospital de ClÃ-nicas de Porto Alegre, Coordenação de Aperfeiçoamento de Pessoal de NÃ-vel Superior, PrÃ-Reitoria de Pesquisa, Universidade Federal do Rio Grande do Sul FIPE-HCPA project 2021-0619
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39792537
PMCPMC11737452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.